Epsilon M&A Deal Report - Therapharm Recherches
Transaction Multiples for the Valuation of Private Companies
ReSearch Pharmaceutical Services / Therapharm Recherches
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Current | ![]() |
![]() |
![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
Date | Acquirer | Target | Country | Multiples | See details |
02/01/2009 | Atrium Innovations | EAB Enzym-Arzneimittel-Berlin | Germany | * | 19636 |
03/08/2008 | Meda | European Pharmaceutical Business of Valeant | Europe | ** | 19599 |
Source: Epsilon Research / EMAT